Gonsalves, D.; Ocanto, A.; Meilan, E.; Gomez, A.; Dominguez, J.; Torres, L.; Fernández, C.; Teja, M.; Garrido, I.; Gonzalez, M.;
et al. First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study. Biomedicines 2025, 13, 2390.
https://doi.org/10.3390/biomedicines13102390
AMA Style
Gonsalves D, Ocanto A, Meilan E, Gomez A, Dominguez J, Torres L, Fernández C, Teja M, Garrido I, Gonzalez M,
et al. First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study. Biomedicines. 2025; 13(10):2390.
https://doi.org/10.3390/biomedicines13102390
Chicago/Turabian Style
Gonsalves, Daniela, Abrahams Ocanto, Eduardo Meilan, Alberto Gomez, Jesus Dominguez, Lisselott Torres, Castalia Fernández, Macarena Teja, Isabel Garrido, Maria Gonzalez,
and et al. 2025. "First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study" Biomedicines 13, no. 10: 2390.
https://doi.org/10.3390/biomedicines13102390
APA Style
Gonsalves, D., Ocanto, A., Meilan, E., Gomez, A., Dominguez, J., Torres, L., Fernández, C., Teja, M., Garrido, I., Gonzalez, M., Gaztañaga, M., Herrero, D., Thuissard, I. J., Andreu, C., Gonzalez, T., González, J. A., Yagüe, J. A., Holgado, E., Alcaraz, D.,
... Couñago, F.
(2025). First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study. Biomedicines, 13(10), 2390.
https://doi.org/10.3390/biomedicines13102390
